Skip to content
The Longevity Archive
ARA-290 in all countries

Legal status · Australia

Is ARA-290 legal in Australia?

InvestigationalHealing & RecoveryEvidence: Moderate

No. ARA-290 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

ARA-290 in Australia at a glance

ClassificationInvestigational, not registered
TGA approval statusNot approved by TGA; investigational
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the ARA-290 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    ARA-290 is being studied in registered clinical trials but has not received TGA marketing approval in Australia.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What ARA-290 is

An EPO-derived peptide that activates tissue-protective repair signaling without raising red blood cells, studied for nerve pain in sarcoidosis.

ARA-290, or cibinetide, is an 11-amino-acid peptide derived from the tissue-protective region of erythropoietin, engineered to avoid EPO's red-blood-cell effects and their clotting risks. It activates the innate repair receptor and has shown nerve fiber regeneration and reduced neuropathic pain in Phase 2 trials for small fiber neuropathy in sarcoidosis.

Mechanism: Selectively activates the innate repair receptor to drive tissue protection and nerve repair without stimulating red blood cell production.

Regulatory history: Investigational, not FDA-approved

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for ARA-290 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

ARA-290 in other countries

Frequently asked questions

Is ARA-290 legal in Australia?

No. ARA-290 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy ARA-290 in Australia?

No approved product exists to buy. In Australia ARA-290 is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is ARA-290 TGA approved?

No. In Australia ARA-290 is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational, not FDA-approved. Evidence level: Moderate.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for ARA-290 live on its compound profile.

ARA-290 profile

This page is general information about the regulatory status of ARA-290 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.